CXCL13 and secondary progressive multiple sclerosis: Finally, SPMS patients with high meningeal inflammation and grey matter pathology showed higher levels of TNF, lymphotoxin (LT)-α and CXCL13 in the CSF compared to patients with less pathology [9].